Weissman, Neil J.

Transcatheter Mitral-Valve Repair in Patients with Heart Failure

Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., et al. (2018) · New England Journal of Medicine

Cardiac Valve Diseases and TreatmentsCardiac Structural Anomalies and Repair

Cited by 3,017

Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management

Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 1,800

Multicenter, placebo-controlled trial of lorcaserin for weight management.

Smith, S. R., Weissman, N. J., Anderson, C. M., Sanchez, M., Chuang, E., Stubbe, S., Bays, H., & Shanahan, W. R. (2010) · New England Journal of Medicine

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 911

The impact of obesity on the short-term andlong-term outcomes after percutaneous coronary intervention: the obesity paradox?

Gruberg, L., Weissman, N. J., Waksman, R., Fuchs, S., Deible, R., Pinnow, E. E., Ahmed, L. M., Kent, K. M., Pichard, A. D., Suddath, W. O., et al. (2002) · Journal of the American College of Cardiology

Coronary Interventions and DiagnosticsAcute Myocardial Infarction Research

Cited by 696

Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes

Kodali, S., Pibarot, P., Douglas, P. S., Williams, M., Xu, K., Thourani, V., Rihal, C. S., Zajarias, A., Doshi, D., Davidson, M., et al. (2015) · European Heart Journal

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 446

Assessment of Paravalvular Regurgitation Following TAVR

Pibarot, P., Hahn, R. T., Weissman, N. J., & Monaghan, M. J. (2015) · JACC: Cardiovascular Imaging

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 277

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

Bohula, E. A., Wiviott, S. D., McGuire, D. K., Inzucchi, S. E., Kuder, J., Im, K., Fanola, C. L., Qamar, A., Brown, C., Budaj, A., et al. (2018) · New England Journal of Medicine

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 265

The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis)

Villines, T. C., Stanek, E. J., Devine, P. J., Turco, M., Miller, M., Weissman, N. J., Griffen, L., & Taylor, A. J. (2010) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthCardiovascular Health and Disease Prevention

Cited by 223

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

Bohula, E. A., Scirica, B. M., Inzucchi, S. E., McGuire, D. K., Keech, A. C., Smith, S. R., Kanevsky, E., Murphy, S. A., Leiter, L. A., Dwyer, J. P., et al. (2018) · The Lancet

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 94

Volumetric intravascular ultrasound quantification of the amount of atherosclerosis and calcium in nonstenotic arterial segments

Tinana, A., Mintz, G. S., & Weissman, N. J. (2002) · The American Journal of Cardiology

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 57